Correlation of baseline self-reported adherence (MMAS) versus directly observed assessment
| NP-reported | |||||
|---|---|---|---|---|---|
| Adherent | Not adherent | κ coefficient | CI | p Value* | |
| Oral† | 205 (88.0%) | 28 (12.0%) | NA | NA | NA |
| Subcutaneous | 300 (79.4%) | 78 (20.6%) | NA | NA | NA |
| Total | 338 (78.6%) | 92 (21.4%) | NA | NA | NA |
| Morisky adherent | 228 | 33 | 0.24 | 0.15–0.33 | <0.0001 |
| Morisky not adherent | 110 | 59 | |||
*Two-sided Pr |Z| Test of H0: κ.
†Oral medications are associated with higher rates of adherence as compared with subcutaneous medications (χ2<6.88; p=0.009).
MMAS, Morisky Medication Adherence Scale; NA, not applicable; NP, nurse practitioner.